Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(2.23)
# 1,221
Out of 4,650 analysts
355
Total ratings
36.78%
Success rate
-1.17%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCYC Bicycle Therapeutics | Reiterates: Buy | $55 | $24.79 | +121.86% | 14 | Oct 24, 2024 | |
| OCGN Ocugen | Reiterates: Buy | $7 | $1.01 | +593.07% | 15 | Oct 23, 2024 | |
| DCTH Delcath Systems | Reiterates: Buy | $22 | $10.50 | +109.52% | 9 | Oct 18, 2024 | |
| CORT Corcept Therapeutics | Maintains: Buy | $45 → $80 | $48.34 | +65.49% | 16 | Oct 18, 2024 | |
| MDWD MediWound | Reiterates: Buy | $28 | $17.57 | +59.36% | 15 | Oct 11, 2024 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $9 → $11 | $8.42 | +30.64% | 2 | Oct 4, 2024 | |
| EVAX Evaxion Biotech | Reiterates: Buy | $14 | $2.84 | +392.96% | 8 | Sep 26, 2024 | |
| DNTH Dianthus Therapeutics | Reiterates: Buy | $40 | $28.12 | +42.25% | 3 | Sep 26, 2024 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Buy | $9 | $0.58 | +1,463.04% | 7 | Sep 17, 2024 | |
| ITOS iTeos Therapeutics | Reiterates: Buy | $46 | $8.93 | +415.12% | 7 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.71 | +572.51% | 9 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.73 | +2,313.79% | 8 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.37 | +196.74% | 10 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.90 | +555.17% | 13 | Aug 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $3 → $0.95 | $0.73 | +31.03% | 4 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.90 | +182.05% | 10 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $63 | $54.36 | +15.89% | 9 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7.5 → $9 | $5.17 | +74.08% | 10 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.84 | +258.81% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.79 | +84.70% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $13 | $2.50 | +420.00% | 4 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $0.84 | +373.48% | 7 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.29 | +63.17% | 8 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $15.74 | +71.54% | 4 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.46 | +1,612.33% | 11 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.53 | +128.76% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5.5 | $4.15 | +32.53% | 11 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.60 | +907.22% | 5 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $60 | $45.66 | +31.41% | 15 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.13 | +784.96% | 11 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.50 | +900.00% | 11 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $0.30 | +4,054.20% | 11 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.77 | +419.55% | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $5.86 | +87.71% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.94 | +407.61% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.82 | +509.76% | 5 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $11.05 | +35.75% | 11 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.83 | +54.37% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.06 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.18 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.04 | +342.26% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.71 | +1,362.93% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.48 | +504.84% | 1 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.02 | +65.56% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.05 | +95.12% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $5.87 | +104.43% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $2.09 | +856.94% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $17.59 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $80 | $3.82 | +1,994.24% | 5 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $8.64 | -30.56% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $6.17 | +143.31% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $3.39 | +873.45% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $5.27 | +80.27% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $8.21 | +170,423.75% | 1 | Mar 5, 2020 |
Bicycle Therapeutics
Oct 24, 2024
Reiterates: Buy
Price Target: $55
Current: $24.79
Upside: +121.86%
Ocugen
Oct 23, 2024
Reiterates: Buy
Price Target: $7
Current: $1.01
Upside: +593.07%
Delcath Systems
Oct 18, 2024
Reiterates: Buy
Price Target: $22
Current: $10.50
Upside: +109.52%
Corcept Therapeutics
Oct 18, 2024
Maintains: Buy
Price Target: $45 → $80
Current: $48.34
Upside: +65.49%
MediWound
Oct 11, 2024
Reiterates: Buy
Price Target: $28
Current: $17.57
Upside: +59.36%
Eton Pharmaceuticals
Oct 4, 2024
Maintains: Buy
Price Target: $9 → $11
Current: $8.42
Upside: +30.64%
Evaxion Biotech
Sep 26, 2024
Reiterates: Buy
Price Target: $14
Current: $2.84
Upside: +392.96%
Dianthus Therapeutics
Sep 26, 2024
Reiterates: Buy
Price Target: $40
Current: $28.12
Upside: +42.25%
ImmunoPrecise Antibodies
Sep 17, 2024
Reiterates: Buy
Price Target: $9
Current: $0.58
Upside: +1,463.04%
iTeos Therapeutics
Sep 16, 2024
Reiterates: Buy
Price Target: $46
Current: $8.93
Upside: +415.12%
Sep 13, 2024
Reiterates: Buy
Price Target: $12
Current: $1.71
Upside: +572.51%
Sep 6, 2024
Reiterates: Buy
Price Target: $18
Current: $0.73
Upside: +2,313.79%
Sep 6, 2024
Reiterates: Buy
Price Target: $10
Current: $3.37
Upside: +196.74%
Aug 29, 2024
Reiterates: Buy
Price Target: $19
Current: $2.90
Upside: +555.17%
Aug 23, 2024
Downgrades: Neutral
Price Target: $3 → $0.95
Current: $0.73
Upside: +31.03%
Aug 21, 2024
Reiterates: Buy
Price Target: $11
Current: $3.90
Upside: +182.05%
Aug 19, 2024
Reiterates: Buy
Price Target: $63
Current: $54.36
Upside: +15.89%
Aug 19, 2024
Maintains: Buy
Price Target: $7.5 → $9
Current: $5.17
Upside: +74.08%
Aug 19, 2024
Initiates: Buy
Price Target: $3
Current: $0.84
Upside: +258.81%
Aug 16, 2024
Reiterates: Buy
Price Target: $7
Current: $3.79
Upside: +84.70%
Aug 16, 2024
Maintains: Buy
Price Target: $9 → $13
Current: $2.50
Upside: +420.00%
Aug 15, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.84
Upside: +373.48%
Aug 15, 2024
Reiterates: Buy
Price Target: $7
Current: $4.29
Upside: +63.17%
Aug 15, 2024
Reiterates: Buy
Price Target: $27
Current: $15.74
Upside: +71.54%
Aug 13, 2024
Reiterates: Buy
Price Target: $25
Current: $1.46
Upside: +1,612.33%
Aug 13, 2024
Reiterates: Buy
Price Target: $3.5
Current: $1.53
Upside: +128.76%
Aug 13, 2024
Reiterates: Buy
Price Target: $5.5
Current: $4.15
Upside: +32.53%
Aug 7, 2024
Reiterates: Buy
Price Target: $6
Current: $0.60
Upside: +907.22%
Aug 2, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $45.66
Upside: +31.41%
Jul 30, 2024
Reiterates: Buy
Price Target: $10
Current: $1.13
Upside: +784.96%
Jun 28, 2024
Reiterates: Buy
Price Target: $5
Current: $0.50
Upside: +900.00%
Jun 14, 2024
Reiterates: Buy
Price Target: $13
Current: $0.30
Upside: +4,054.20%
May 10, 2024
Reiterates: Buy
Price Target: $4
Current: $0.77
Upside: +419.55%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $5.86
Upside: +87.71%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $3.94
Upside: +407.61%
Mar 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.82
Upside: +509.76%
Mar 14, 2024
Reiterates: Buy
Price Target: $15
Current: $11.05
Upside: +35.75%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.83
Upside: +54.37%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.06
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.18
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $2.04
Upside: +342.26%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.71
Upside: +1,362.93%
Jan 4, 2023
Initiates: Buy
Price Target: $15
Current: $2.48
Upside: +504.84%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $3.02
Upside: +65.56%
Nov 4, 2022
Maintains: Buy
Price Target: $3 → $4
Current: $2.05
Upside: +95.12%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $5.87
Upside: +104.43%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $2.09
Upside: +856.94%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $17.59
Upside: -
Feb 17, 2022
Maintains: Buy
Price Target: $150 → $80
Current: $3.82
Upside: +1,994.24%
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $8.64
Upside: -30.56%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $6.17
Upside: +143.31%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $3.39
Upside: +873.45%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $5.27
Upside: +80.27%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $8.21
Upside: +170,423.75%